PrimeRFP SCOUT · Federal Contract Recompete Brief

N6854624F6042Benzodiazepine reagent KITS — Microgenics Corp

Microgenics Corp holds $4.3M across 166 federal awards, concentrated at Department of Defense (DOD). This PIID sits alongside 3 related awards under parent N6264523D5009. PoP ended Dec 11, 2024 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Navy-Marine Corps Public Health Ctr

Awarding office

Microgenics Corp

Recipient

Dec 11, 2024

PoP end

$134K

Obligated

$134K

Potential

334516

NAICS

6550

PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Microgenics Corp — $90

Contract facts

Federal

Contract numberN6854624F6042

Also listed asN68546-24-F-6042

Also listed asN6264523D5009-N6854624F6042

AgencyNavy-Marine Corps Public Health Ctr

Awarding officeNavy-Marine Corps Public Health Ctr

Awarding agencyDepartment of Defense (DOD)

Funding agencyDepartment of Defense (DOD)

IncumbentMicrogenics Corp

CAGE1MRF6

UEIE7WGWEK19Y79

NAICS334516

No full NAICS 334516 intel page yet. Browse NAICS intelligence

PSC6550

Parent IDIQ / IDVN6264523D5009

Place of performanceFREMONT CA

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

PoP startJul 23, 2024

PoP end (current)Dec 11, 2024

Obligated$134K

Current value$134K

Potential value$134K

BENZODIAZEPINE REAGENT KITS is a federal award for Navy-Marine Corps Public Health Ctr held by Microgenics Corp. Estimated value $134K ($134K obligated). Current period of performance ends Dec 11, 2024. Place of performance: FREMONT CA.

Recompete timing

Public

● Past PoP end (618 days ago)

Current PoP ended Dec 11, 2024 (618 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Microgenics Corp — $4.3M obligated across 166 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).

% of firm-wide obligated ($4.3M) · all agencies

Department of Defense (DOD)$3.9M · 91%Department of Veterans Affairs (VA)$411K · 10%

Open full company profile →

Related awards

Same parent · incumbent

36C26326N0005

TOXICOLOGY REAGENTS - MODIFICATION TO ADD A LINE ITEM TO THE BASE YEAR AND EACH OPTION YEA…

$165K

Sep 30, 2026

W81K0226FA033

BENZODIAZEPINE REAGENT KITS FOR TRIPLER ARMY MEDICAL CENTER (TAMC), HAWAII.

$164K

Oct 15, 2026

FA301626F0056

BENZODIAZEPINE REAGENT KITS

$176K

Dec 31, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract N6854624F6042?

N6854624F6042 (Benzodiazepine reagent KITS) is a Navy-Marine Corps Public Health Ctr award with a potential value of $134K, currently held by Microgenics Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is N68546-24-F-6042?

N68546-24-F-6042 is the dashed form of PIID N6854624F6042 (Benzodiazepine reagent KITS), held by Microgenics Corp. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded N6854624F6042?

Navy-Marine Corps Public Health Ctr awarded N6854624F6042 to Microgenics Corp (potential $134K).

Who is the incumbent on N6854624F6042?

Microgenics Corp is the incumbent with $4.3M across 166 related awards in SCOUT’s public footprint. The current period of performance ends Dec 11, 2024.

When does Microgenics Corp’s N6854624F6042 come up for recompete?

SCOUT tracks a period-of-performance end of Dec 11, 2024. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 19, 2026 · refreshed monthlyLatest procurement action Jul 23, 2024